Response of histiocytoses to imatinib mesylate: fire to ashes. J Clin Oncol 2010 Nov 01;28(31):e633-6
Date
08/25/2010Pubmed ID
20733125DOI
10.1200/JCO.2010.29.9073Scopus ID
2-s2.0-78149267163 (requires institutional sign-in at Scopus site) 75 CitationsAuthor List
Janku F, Amin HM, Yang D, Garrido-Laguna I, Trent JC, Kurzrock RAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Administration, OralAdult
Aged
Antineoplastic Agents
Benzamides
Brain Neoplasms
Diagnosis, Differential
Drug Administration Schedule
Erdheim-Chester Disease
Female
Genes, abl
Histiocytosis, Langerhans-Cell
Humans
Imatinib Mesylate
Lung Neoplasms
Male
Middle Aged
Mutation
Piperazines
Positron-Emission Tomography
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-kit
Pyrimidines
Receptor, Platelet-Derived Growth Factor alpha
Receptor, Platelet-Derived Growth Factor beta
Remission Induction
Tomography, X-Ray Computed
Treatment Outcome